We kickstart Day Two by asking senior leaders from across the supply chain how they are confronting our environmental challenges. What does a holistic view to environmental sustainability look like and how can we ensure we are future-proofing our supply chains to withstand greater sustainability commitments in the future?

Core focus areas to include:

>> The Holistic Approach: Packaging, transport, processes, people – how do we bring it all together to find an all-encompassing approach that allows us to truly confront the environmental challenge?

>> Identifying New Areas of Opportunity: How has the rapidity of technology change redefined what is possible concerning reducing our environmental impacts?

>> Implications for Risk Management: How can we ensure that we are ambition in rolling out sustainability innovations without burdening our products with additional risk?

>> Implications for Cost Management: In what ways can we make an investment and cost argument for driving sustainability initiatives across the supply chain?

Mark Everitt

Qualification Engineer
AstraZeneca

See Bio

Jeremy Hertel

Director of Compliance, ESG & Global Logistics
Inguran

See Bio

In this morning’s first focus presentation on environmental sustainability, we explore how sustainable packaging innovation is redefining what can be achieved. How make more effective packaging decisions without increasing the risk of temperature excursions?

Core focus areas to include:

>> Rethinking Packaging Design: We investigate how innovations in packaging design are allowing the pharmaceutical industry to drive its sustainability commitments

>> Breaking Down the Barriers to Adoption: What are the cost implications of using more sustainable packaging? How can we make the business case for its adoption?

>> Reaching for the Renewable: What are the implications of renewable materials for packaging design? What are the implications of these materials for quality assurance?

>> Implications for Transportation: How can packaging and transportation work in tandem to deliver real and lasting sustainability benefits for the supply chain?

How does it work? Choose a 45-minute discussion on a pressing topic. Interact with your peers, identifying contemporary challenges and novel approaches to confronting them. Each roundtable is led by a subject matter expert.

A 30-minute feedback session will follow the discussions, where the roundtable leaders will share the key findings with the audience.

GROUP A

REDUCING THE ENVIRONMENTAL IMPACT OF TRANSPORTATION

GROUP B

HOW CAN REGULATORS BE BROUGHT UP TO SPEED ON TECHNOLOGICAL INNOVATION?

GROUP C

REDUCING THE ENVIRONMENTAL IMPACT OF PACKAGING

GROUP D

IMPROVING DATA ACCESSIBILITY & SHARING WITH EXTERNAL PARTNERS

GROUP E

PROTECTING QUALITY FOR PERSONALISED MEDICINE AND ADVANCED THERAPIES

GROUP F

OVERCOMING THE IMPACT OF SUPPLY CHAIN DISRUPTION ON LAST MILE DELIVERY

In this next keynote, we turn towards the supply chain and logistics challenges associated with new developments in personalized medicines and advanced therapies. How are operators meeting the demands of these new products?

Core focus areas to include:

>> Mapping Out the Next Decade: What is the trajectory for these new advanced therapies and what are the specific implications for the temperature-controlled supply chain?

>> Immediate Operational Considerations: How are operators adapting in the here and now? We explore the immediate challenges and how they are being met

>> The Lessons from Clinical Trial Supply: Learn how experiences from the clinical trial supply side can hold important lessons for the wider supply chain and logistics network

>> The Impact of Patient-Centricity: How will the move towards a more patient-centric model combine with these new therapies to create new opportunities and challenges?

In this next keynote, we explore how to bring together all your tools and people to build a regulatory compliance framework that will set you up for future success.

Core focus areas to include: 

>> The Value of the Your Data: How are we leveraging our data to both demonstrate regulatory compliance and identify areas of improvement? 

>> Exploration of Best Practice: Where can we find best contemporary practice and ensure that we have the capacity to implement it ourselves?

>> Evolving Regulatory Standards: How is the landscape for the temperature controlled supply chain evolving and how can we stay ahead of the curve?

>> Collaborating with Regulators: We explore how operators and regulators can continue to work closer together to ensure patient safety and supply chain integrity

We close this year’s event with a look to the horizon, asking how current challenges are evolving as well as the opportunities we have to mitigate risks, protect product integrity, and operate more effectively.

Core focus areas to include:

>> A Confident Outlook: Given the pace of technology change, success sharing and the evolution of best practice, which challenges are becoming easier to confront?

>> New Technologies: We investigate which technologies will transform the temperature control and logistics space. How do we prepare our supply chains for adoption?

>> The Role of Logistics: How is the role of logistics evolving in line with the pharmaceutical industry more generally? What does it mean for Logistics role in the value chain?

>> Key Conference Take-Aways: What are the key lessons we can draw from this year’s event? How has our perspective on certain challenges shifted or evolved?